All Disease Treatment & Prevention articles – Page 4
-
NewsUnzipping mRNA rallies plant cells to fight infection
Scientists studying a plant called Arabidopsis thaliana have discovered short snippets of folded RNA that are unzipped in the presence of a pathogen to allow plant cells to make defense proteins to fight infection.
-
OpinionHas a viral contribution to Alzheimer’s disease been in front of our noses this whole time?
The concept that a viral infection may induce pathology in regions far from its active location is gaining traction. Could this phenomenon also be at play in Alzheimer’s disease?
-
NewsResearchers target lifecycle of parasite behind Chagas disease
Researchers are studying the signaling pathway that leads the parasite behind Chagas disease to transform and reproduce.
-
FeaturesSourcing the next generation of drug leads from the human microbiome
Could the answers to the problem of antimicrobial resistance be found inside the human body?
-
NewsHigh-tech microscope using AI detects malaria in returning travellers
Researchers have tested the accuracy of an automated microscope combined with AI software to identify malaria parasites in blood samples – an additional diagnostic approach to disease detection.
-
NewsReactivation compound could be latest weapon against HIV
A research team has identified a molecular compound that activates latent HIV-1 in cells, showing promise for HIV treatments.
-
NewsSecond gene implicated in malaria chloroquine resistance evolution
How malaria parasites evolved to evade a major antimalarial drug has long been thought to involve only one key gene. Now, scientists have shown a second key gene is also involved in malaria’s resistance to the drug chloroquine.
-
NewsTobacco plant engineered to act as drug factory
Researchers have engineered a close relative of tobacco, Nicotiana benthamiana, to churn out peptides with antibiotic activity against some of the nastiest pathogens known to medicine.
-
NewsMeet Ginger: the gene-edited calf resistant to BVDV
Scientists introduce Ginger, the first gene-edited calf with reduced susceptibility to a major viral pathogen.
-
NewsProtein may pave way to eliminating HIV latency
Researchers have identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor that shuts down viral protein production and helps virus-infected cells to escape from anti-HIV therapy and immune responses.
-
NewsScientists build human lungs in dish to test drugs
Scientists have developed a step-by-step blueprint to create advanced human lung models in the lab, which they say will accelerate the discovery and development of new drugs and reduce reliance on animal testing.
-
NewsNew biologic effective against major infection in early tests
Researchers have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.
-
News‘Antibiotic culture’ permeates US hospital ICUs, study finds
A new study reveals that there continues to be an ’antibiotic culture’ in US hospitals, meaning that the preference for antibiotics is related to their perceived role as ’magic bullets’.
-
NewsProtein domain common to plants and animals plays role in COVID-19 infection
Scientists exploring bioenergy plant genetics have made a surprising discovery - a protein domain that could lead to new COVID-19 treatments.
-
NewsResearchers make new optimal recommendations for fungicide resistance management
Fungicide application, while helpful in controlling plant diseases, has complicated limitations that may cost growers both peace of mind and quantity of yield. Plant pathogens which would otherwise be killed off by fungicides can evolve, developing resistance that renders the standard dose of fungicide application ineffective. Source: Maccheek ...
-
NewsScientists discover unknown circovirus involved in human hepatitis
Scientists have identified a previously unknown species of circovirus, provisionally named human circovirus 1 (HCirV-1).
-
NewsStudy of simple acoziborole regime raises hope for elimination of sleeping sickness in Africa
The Drugs for Neglected Diseases initiative (DNDi) and Sanofi have announced treatment success rates of up to 95% from a Phase II/III study investigating the safety and efficacy of single-dose acoziborole, a potentially transformative investigational treatment for sleeping sickness.
-
NewsToxic bacteria find floating homes on microfibres in the Mediterranean Sea
Almost 200 species of bacteria have colonized microfibres in the Mediterranean Sea, including one that causes food poisoning in humans, according to a new study.
-
NewsBiovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).
-
NewsNew monkeypox study increases fear of potential escalation in central Africa
A new study of monkeypox infections in a remote area of the Democratic Republic of the Congo (DRC) shows transmission rates rising closer to the point where outbreaks are likely to be larger and more frequent.
